Subtle modifications to a thieno[2,3-d]pyrimidine scaffold yield negative allosteric modulators and agonists of the dopamine D2 receptor

Eur J Med Chem. 2019 Apr 15:168:474-490. doi: 10.1016/j.ejmech.2019.01.061. Epub 2019 Feb 11.

Abstract

We recently described a structurally novel series of negative allosteric modulators (NAMs) of the dopamine D2 receptor (D2R) based on thieno[2,3-d]pyrimidine 1, showing it can be structurally simplified to reveal low molecular weight, fragment-like NAMs that retain robust negative cooperativity, such as 3. Herein, we report the synthesis and functional profiling of analogues of 3, placing specific emphasis on examining secondary and tertiary amino substituents at the 4-position, combined with a range of substituents at the 5/6-positions (e.g. aromatic/aliphatic carbocycles). We identify analogues with diverse pharmacology at the D2R including NAMs with sub-μM affinity (9h) and, surprisingly, low efficacy partial agonists (9d and 9i).

Keywords: Agonists; Dopamine D(2) receptor; NAMs; Negative allosteric modulators; Thieno[2,3-d]pyrimidines.

MeSH terms

  • Allosteric Regulation / drug effects
  • Animals
  • CHO Cells
  • Cells, Cultured
  • Cricetulus
  • Dose-Response Relationship, Drug
  • Humans
  • Molecular Structure
  • Pyrimidines / chemical synthesis
  • Pyrimidines / chemistry
  • Pyrimidines / pharmacology*
  • Receptors, Dopamine D2 / agonists*
  • Structure-Activity Relationship

Substances

  • DRD2 protein, human
  • Pyrimidines
  • Receptors, Dopamine D2
  • thieno(2,3-d)pyrimidine